Vnitr Lek 2015, 61(9):755-757

Radiojod u nízkorizikového karcinomu štítné žlázy - editorial

Jiří Horáček1,2
1 IV. interní hematologická klinika LF UK a FN Hradec Králové, přednosta doc. MUDr. Pavel Žák, Ph.D.
2 Katedra interních oborů LF UK Hradec Králové, vedoucí prof. MUDr. Jan Bureš, CSc.

Received: August 9, 2015; Published: September 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáček J. Radiojod u nízkorizikového karcinomu štítné žlázy - editorial. Vnitr Lek. 2015;61(9):755-757.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vlček P, Nováková D, Vejvalka J et al. Návrh optimálního léčebného postupu v léčbě nízkorizikového karcinomu štítné žlázy. Vnitř Lék 2015; 61(9): 769-777. Go to PubMed...
    2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97(5): 418-428. Go to original source... Go to PubMed...
    3. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009; 115(16): 3801-3807. Go to original source... Go to PubMed...
    4. Pacini F, Schlumberger M, Dralle H et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154(6): 787-803. Go to original source... Go to PubMed...
    5. Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19(11): 1167-1214. Go to original source... Go to PubMed...
    6. Schlumberger M, Catargi B, Borget I et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. New Engl J Med 2012; 366(18): 1663-1673. Go to original source... Go to PubMed...
    7. Malick U, Harmer C, Yap B et al. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. New Engl J Med 2012; 366(18): 1674-1685. Go to original source... Go to PubMed...
    8. Alexander EK, Larsen PR. Radioiodine for thyroid cancer - is less more? New Engl J Med 2012; 366(18): 1732-1733. Go to original source... Go to PubMed...
    9. Iyer NG, Morris LGT, Tuttle RM et al. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 2011; 117(19): 4439-4446. Go to original source... Go to PubMed...
    10. Blumhardt R, Wolin EA, Phillips WT et al. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review. Endocr Relat Cancer 2014; 21(6): R473-R484. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.